跳至主要内容
临床试验/NL-OMON43072
NL-OMON43072已完成4 期

Infection prevention and immune modulation by bacterial lysates in patients with asthma: gaining insight into the mechanism of an old therapy - BREATHE

Sint Franciscus Gasthuis0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
75

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 99(—)

入选标准

  • Patients with proven asthma (airway responsiveness proven by reversibility and histamine PC20 < 8 mg/ml)) who have recurrent airway signs and symptoms despite optimal maintenance medication (medium/high dose inhalation corticosteroid and long-acting *2-agonist; GINA 4).;Specific inclusion criteria
  • - * 2 documented asthma exacerbations in the past winter season (see definition below)
  • - and Asthma Control Questionnaire (ACQ) > 1.5 despite maintenance medication

排除标准

  • - Other relevant respiratory conditions, e.g. OSAS, bronchiectasis
  • - Systemic immunological diseases
  • - Current smoking or past smoking 10 pack years
  • - Other untreated co-morbidity, such as gastro-esophageal reflux disease, ENT problems, psychological disorders
  • - Non-compliance to current medication or inhalation technique
  • - Communication difficulties
  • - Pregnancy or planned pregnancy within 2 years

研究者

相似试验